Cargando…
Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
To evaluate the efficacy and safety of a new treatment for COVID-19 vs. standard care, certain key endpoints are related to the duration of a specific event, such as hospitalization, ICU stay, or receipt of supplemental oxygen. However, since patients may die in the hospital during study follow-up,...
Autores principales: | McCaw, Zachary R., Tian, Lu, Sheth, Kevin N., Hsu, Wan-Ting, Kimberly, W. Taylor, Wei, Lee-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486285/ https://www.ncbi.nlm.nih.gov/pubmed/32927092 http://dx.doi.org/10.1016/j.cct.2020.106145 |
Ejemplares similares
-
Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations
por: McCaw, Zachary R, et al.
Publicado: (2022) -
Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence
por: Dehbi, Hakim‐Moulay, et al.
Publicado: (2022) -
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study
por: Sun, Ryan, et al.
Publicado: (2021) -
The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023) -
Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies
por: Wang, Xiaofei, et al.
Publicado: (2023)